GIP/GLP-1 Peptide Vial
Weight Loss

Tirzepatide

None downtimeFDA-Cleared
Book This Treatment

Duration

Ongoing weekly injections

Downtime

None

Results

4–8 weeks for initial results

About This Treatment

Tirzepatide is a dual-action (GIP + GLP) medication for weight management that targets two very important hormones needed for regulating blood sugar and appetite. By mimicking these hormones, Tirzepatide helps control hunger, improve metabolism, and promote sustained weight loss. An ideal treatment for those struggling with obesity or difficulty losing weight. This treatment offers significant potential for for long-term weight and health management.

Ideal For

Significant weight lossAppetite suppressionMetabolic healthBlood sugar managementLong-term weight control
Common Questions

Frequently Asked Questions

Tirzepatide is a month-long treatment administered via a weekly injection, in 4 weekly doses. This can be done in-office if you prefer, plus we’ll teach you how you can do at home.

Tirzepatide has been shown to be safe for both short-term and long-term use under the supervision of a healthcare or clinical provider. Long-term weight management goals are easily able to be reached.

Tirzepatide is a dual-acting peptide consisting of GIP an GLP-1. They mimic the crucial hormones needed for blood sugar control and appetite regulation. Most effective for weight loss, and widely used for patients with or without type 2 diabetes.

Recommended treatment plans vary by patient, but most see results within a few weeks, however, we ask that you maintain the program for at least 1-3 months. Your provider will monitor progress and adjust the dosage or treatment plan as needed.

The most common side effects include nausea, diarrhea, and decreased appetite. These symptoms usually lessen over time as the body adjusts to the medication.

Take the Next Step

Book Your Tirzepatide

Same-day appointments often available. Our team will build a personalized plan for your goals.